Not Yet RecruitingNot Applicable

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

United States60 participantsStarted 2026-06-01

Plain-language summary

The purpose of this research is to evaluate a new, web-based program among patients with pancreatic cancer aimed at reducing psychosocial stress.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Greater than 18 years of age.
✓. Spanish or English speaker with ability to read one of these languages.
✓. Diagnosis of pancreatic cancer.
✓. Patients diagnosed with pancreatic neuroendocrine tumor (PNET).

Exclusion criteria

✕. Patients unable to read Spanish or English, as participants will not be unable to complete surveys.
✕. Have a history of severe psychiatric illness (e.g., psychosis, active suicidality, inpatient treatment in the past 12 months).
✕. Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements.

What they're measuring

Percentage of Participants Recruited

Timeframe: Up to 1 year.

Percentage of Participants Retained

Timeframe: Up to 1 year.

Percentage of Study Participation

Timeframe: Up to 1 year.

Number of Calls

Timeframe: Up to 10 weeks.

Theoretical Framework on Acceptability Questionnaire

Timeframe: Up to 10 weeks.

Functional Assessment of Cancer Therapy (FACT) - Functional Hepatobiliary-Pancreatic Symptom Index (FHSI)-18

Timeframe: Up to 10 weeks.

Patient-Reported Outcomes Measurement Information System - Pain Short Form

Timeframe: Up to 10 weeks.

Patient-Reported Outcomes Measurement Information System - Fatigue Short Form

Timeframe: Up to 10 weeks.

Trial details

NCT IDNCT06893276

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11-27

Contact for this trial

Sara Fleszar-Pavlovic, PhD

305-243-8498 sarafleszarpavlovic@med.miami.edu

View on ClinicalTrials.gov More Pancreatic Cancer trials

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Greater than 18 years of age.
✓. Spanish or English speaker with ability to read one of these languages.
✓. Diagnosis of pancreatic cancer.
✓. Patients diagnosed with pancreatic neuroendocrine tumor (PNET).

Exclusion criteria

✕. Patients unable to read Spanish or English, as participants will not be unable to complete surveys.
✕. Have a history of severe psychiatric illness (e.g., psychosis, active suicidality, inpatient treatment in the past 12 months).
✕. Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements.

What they're measuring

Percentage of Participants Recruited

Timeframe: Up to 1 year.

Percentage of Participants Retained

Timeframe: Up to 1 year.

Percentage of Study Participation

Timeframe: Up to 1 year.

Number of Calls

Timeframe: Up to 10 weeks.

Theoretical Framework on Acceptability Questionnaire

Timeframe: Up to 10 weeks.

Functional Assessment of Cancer Therapy (FACT) - Functional Hepatobiliary-Pancreatic Symptom Index (FHSI)-18

Timeframe: Up to 10 weeks.

Patient-Reported Outcomes Measurement Information System - Pain Short Form

Timeframe: Up to 10 weeks.

Patient-Reported Outcomes Measurement Information System - Fatigue Short Form

Timeframe: Up to 10 weeks.